Literature DB >> 7766817

Alkylation of DNA by the nitrogen mustard bis(2-chloroethyl)methylamine.

M R Osborne1, D E Wilman, P D Lawley.   

Abstract

Alkylation of DNA by the nitrogen mustard bis(2-chloroethyl)methylamine (mechlorethamine; HN2) gave four principal products, derived by mono-alkylation of guanine at N-7 and adenine at N-3 and by cross-linking of guanine to guanine or guanine to adenine at these positions. These products were isolated by hydrolysis from DNA at neutral pH, followed by ion-exchange chromatography on SP-Sephadex and reversed phase chromatography on ODS. They were characterized by identification with products from the reaction of nitrogen mustard with adenine or deoxyguanylic acid, and by their UV, mass, and proton magnetic resonance spectra.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766817     DOI: 10.1021/tx00044a018

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  15 in total

1.  Sulfur Mustard Analog Mechlorethamine (Bis(2-chloroethyl)methylamine) Modulates Cell Cycle Progression via the DNA Damage Response in Human Lung Epithelial A549 Cells.

Authors:  Yi-Hua Jan; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2019-04-22       Impact factor: 3.739

Review 2.  DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.

Authors:  Claire Gourzones-Dmitriev; Alboukadel Kassambara; Surinder Sahota; Thierry Rème; Jérôme Moreaux; Pascal Bourquard; Dirk Hose; Philippe Pasero; Angelos Constantinou; Bernard Klein
Journal:  Cell Cycle       Date:  2013-08-09       Impact factor: 4.534

3.  Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells.

Authors:  Erin D Michaelson-Richie; Xun Ming; Simona G Codreanu; Rachel L Loeber; Daniel C Liebler; Colin Campbell; Natalia Y Tretyakova
Journal:  J Proteome Res       Date:  2011-04-29       Impact factor: 4.466

4.  A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.

Authors:  Kaushik Mitra; John C Marquis; Shawn M Hillier; Peter T Rye; Beatriz Zayas; Annie S Lee; John M Essigmann; Robert G Croy
Journal:  J Am Chem Soc       Date:  2002-03-06       Impact factor: 15.419

5.  Direct and Topoisomerase II Mediated DNA Damage by Bis-3-chloropiperidines: The Importance of Being an Earnest G.

Authors:  Alice Sosic; Ivonne Zuravka; Nina-Katharina Schmitt; Angelica Miola; Richard Göttlich; Dan Fabris; Barbara Gatto
Journal:  ChemMedChem       Date:  2017-08-10       Impact factor: 3.466

6.  Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line.

Authors:  Francesca Gruppi; Leila Hejazi; Plamen P Christov; Sesha Krishnamachari; Robert J Turesky; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2015-09-01       Impact factor: 3.739

7.  Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence.

Authors:  G B Bauer; L F Povirk
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

8.  Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical α-anomer.

Authors:  Irina G Minko; Carmelo J Rizzo; R Stephen Lloyd
Journal:  J Biol Chem       Date:  2017-09-28       Impact factor: 5.157

9.  Histopathological and immunohistochemical evaluation of nitrogen mustard-induced cutaneous effects in SKH-1 hairless and C57BL/6 mice.

Authors:  Anil K Jain; Neera Tewari-Singh; Swetha Inturi; David J Orlicky; Carl W White; Rajesh Agarwal
Journal:  Exp Toxicol Pathol       Date:  2013-12-25

Review 10.  DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

Authors:  Ida Casorelli; Cecilia Bossa; Margherita Bignami
Journal:  Int J Environ Res Public Health       Date:  2012-07-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.